RohdeDoc ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.7% 7.6% 6.5% 10.4% 17.0%  
Credit score (0-100)  25 31 36 22 10  
Credit rating  BB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,061 817 999 796 0.7  
EBITDA  557 272 455 392 -177  
EBIT  557 272 455 392 -177  
Pre-tax profit (PTP)  554.4 265.7 344.2 386.3 -180.5  
Net earnings  432.4 207.3 245.0 300.1 -180.5  
Pre-tax profit without non-rec. items  554 266 344 386 -180  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  725 820 950 1,133 830  
Interest-bearing liabilities  24.9 29.8 26.1 26.5 36.8  
Balance sheet total (assets)  1,118 950 1,301 1,254 896  

Net Debt  -801 -684 -934 -1,227 -809  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,061 817 999 796 0.7  
Gross profit growth  6.6% -23.0% 22.3% -20.3% -99.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,118 950 1,301 1,254 896  
Balance sheet change%  36.4% -15.0% 37.0% -3.6% -28.5%  
Added value  557.0 272.2 454.7 391.8 -177.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  52.5% 33.3% 45.5% 49.2% -24,888.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  57.5% 26.3% 40.4% 30.7% -16.5%  
ROI %  95.7% 34.0% 49.8% 36.7% -17.5%  
ROE %  76.6% 26.8% 27.7% 28.8% -18.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  64.9% 86.3% 73.1% 90.3% 92.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -143.8% -251.4% -205.5% -313.3% 456.5%  
Gearing %  3.4% 3.6% 2.7% 2.3% 4.4%  
Net interest  0 0 0 0 0  
Financing costs %  14.4% 23.8% 395.5% 21.0% 10.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.8 7.3 3.7 10.3 13.5  
Current Ratio  2.8 7.3 3.7 10.3 13.5  
Cash and cash equivalent  825.9 714.2 960.5 1,254.0 845.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  725.3 819.6 950.3 1,132.5 830.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  557 272 455 392 -177  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  557 272 455 392 -177  
EBIT / employee  557 272 455 392 -177  
Net earnings / employee  432 207 245 300 -180